Derek Jones
Dermatology · Los Angeles, CANPI 1245264837
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $231,758 of the $271,927 with a category attached, or 85.2%. AbbVie accounts for 85.7% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $81,022 and has fallen 54.0% since, to $37,235 in 2025. Among dermatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 285 payments — averaging $954.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$233K
- Merz North America, Inc.$26K
- Endo Pharmaceuticals Inc.$7K
- Galderma Laboratories, L.p.$5K
- Novartis$318
- Revance Therapeutics, Inc.$216
- plus $603 from 13 others
Across 139 payments — averaging $6177.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$811K
- Merz North America, Inc.$46K
- Galderma Laboratories, L.p.$1K
What the payments were for
- Consulting fees$231,75885%
- Speaking & faculty fees$4,4462%
- Travel & lodging$30,89311%
- Food & beverage$4,8302%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 189 | $233,149 |
| Merz North America, Inc. | 13 | $26,046 |
| Endo Pharmaceuticals Inc. | 11 | $7,021 |
| Galderma Laboratories, L.p. | 19 | $4,573 |
| Novartis | 19 | $318 |
| Revance Therapeutics, Inc. | 6 | $216 |
| LEO Pharma Inc. | 5 | $110 |
| Sun Pharmaceutical Industries Inc. | 3 | $84 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $63 |
| Lilly USA, LLC | 3 | $61 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $53 |
| Johnson & Johnson | 2 | $48 |
| Almirall LLC | 2 | $46 |
| EPI Health, LLC | 2 | $32 |
| Amgen | 1 | $25 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $24 |
| Biofrontera Inc. | 1 | $23 |
| Sanofi | 1 | $19 |
| Aclaris Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$71,078
- BOTOX$33,977
- XEOMIN$25,838
- KYBELLA$3,080
How this compares
$271,927 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minoxidil | 18 | $176 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Los Angeles
- April ArmstrongLos Angeles$2.3M
- Jennifer HsiaoLos Angeles$746K
- Christopher HoLos Angeles$731K
- Howard SofenLos Angeles$345K
- Nada ElbulukLos Angeles$297K
- Pearl GrimesLos Angeles$256K
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.